Based on this understanding, theoretical therapeutic strategies have been proposed: It is hypothesized that by inhibiting MCT1/4 to block lactate flux, or by directly neutralizing the acidic environment, it may be possible to restore the suppressed anti-tumor immune function, thereby significantly enhancing response rates to immune checkpoint inhibitors (ICIs). Here, SLC16A1 is linked to neoplasm.